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A B S T R A C T
Introduction. Premature ejaculation (PE) is one of the most prevalent male sexual problems. The Premature
Ejaculation Diagnostic Tool (PEDT) is a suitable patient-reported outcome measure for the assessment of PE.
Aim. To examine the psychometric proporties of a translated and culturally adapted version of the PEDT in a
sample of Iranian men suffering from PE.
Methods. Two independent samples were compared, one including patients with PE based on the DSM-IV-TR
criteria (n = 269) and the other including healthy men without PE (n = 289). A backward–forward translation
procedure was used to translate the PEDT into Persian. Both samples were asked to ﬁll in the PEDT twice—at
baseline and 4 weeks later.
Main Outcome Measures. Internal consistency, test–retest reliability, convergent validity, factor structure, measure-
ment invariance across sexual health status (i.e., between men with and without PE).
Results. Mean ages of men without and with PE were 34.9 and 35.3 years, respectively. Cronbach’s alpha coefﬁcient
for the total PEDT score was 0.89. All items and the total score were remarkably consistent between the two
measurement points. All ﬁve PEDT items correlated at r = 0.40 or greater with their own scale, indicating good
convergent validity. There was a high and signiﬁcant correlation (r = −0.82, P < 0.001) between the PEDT score and
IELT. Healthy men reported lower scores (fewer complaints) on the PEDT compared with the PE group. A single-
factor model was found to be best-ﬁtting in the exploratory factor analysis; this was conﬁrmed by conﬁrmatory factor
analysis. The PEDT was invariant across sexual health status and perceived similarly by men with and without PE.
Conclusion. The results provide evidence for good reliability and validity of the Iranian version of the PEDT. The
questionnaire therefore represents a suitable tool for screening PE in Iranian men. Pakpour AH, Yekaninejad MS,
Nikoobakht MR, Burri A, and Fridlund B. Psychometric properties of the Iranian version of the Premature
Ejaculation Diagnostic Tool. Sex Med 2014;2:31–40.
Key Words. PEDT; Premature Ejaculation; Diagnostic Tool; Intravaginal Ejaculatory Latency Time; Iran; Psycho-
metric Validation
Introduction
Sexual problems are prevalent across the generalpopulation, and it is estimated that up to 50%
of sexually active people suffer from some type of
sexual problem at least at one point in their lives [1].
The three major categories of male sexual dysfunc-
tion are ejaculatory dysfunction (such as premature
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ejaculation, PE), erectile dysfunction (ED), and
hypoactive sexual desire disorder. Epidemiologic
studies suggest that PE is the most prevalent sexual
problem in men [2,3] with prevalence estimates
ranging from 10% up to 40% [4–7]. However,
survey ﬁndings vary considerably due to the use of
inconsistent deﬁnitions of sexual problems and the
application of different assessment methods.
Various deﬁnitions of PE exist, and a universally
accepted deﬁnition of PE has yet to be established.
According to the International Society for Sexual
Medicine, PE is deﬁned as “a male sexual dysfunc-
tion characterized by ejaculation which always or
nearly always occurs prior to or within about one
minute of vaginal penetration; and, inability to
delay ejaculation on all or nearly all vaginal pen-
etrations; and, negative personal consequences,
such as distress, bother, frustration and/or the
avoidance of sexual intimacy” [8]. The Diagnostic
and Statistical Manual of Mental Disorders (4th
edition, text revision; DSM-IV-TR), in contrast,
emphasizes the emotional and interpersonal
impact of ejaculation in the deﬁnition of PE,
describing it as “a persistent or recurrent ejacula-
tion with minimal sexual stimulation before, on, or
shortly after penetration and before the person
wishes it and [that] causes marked distress or inter-
personal difﬁculty and is not due to the direct
effects of a substance.” PE can be subclassiﬁed into
a primary type (lifelong) that starts when a man
ﬁrst becomes sexually active and a secondary type
that develops later in life in a man who previously
had an acceptable level of ejaculatory control.
Despite considerable research advances, the etiol-
ogy of PE is still not fully understood [9]. Research
advances are often hindered by the reluctance of
patients to discuss their condition with their phy-
sicians [10,11]. Most likely, a combination of
physical and psychological factors contribute to
the development of PE. The factors so far identi-
ﬁed as associated with PE are many and include
age, lifestyle [12], distress [13], and medical and
psychological comorbidities such as depression
[14], anxiety [14,15], social phobia [16], diabetes
[17], prostate diseases [18,19], and ED [20].
PE causes substantial suffering and disability in
daily living. It not only impacts on the psychologi-
cal health of individuals (e.g., self-conﬁdence,
tension, guilt, fear) but also affects relationship
satisfaction and therefore overall quality of life. PE
is usually diagnosed via medical examination and
by assessing anamnestic information on the
patient’s sexual history. Additionally, several ques-
tionnaires based on patient-reported outcome
(PRO) exist, allowing the subjective assessment of
PE and the monitoring of treatment outcomes.
Although there are also objective measures avail-
able for the assessment of ejaculatory function,
such as intravaginal ejaculation latency time
(IELT; deﬁned as the time between the start of
vaginal intromission and the start of intravaginal
ejaculation), they do not provide any informat-
ion about changes in conﬁdence and satisfaction
of participants regarding their sexual function,
which represent an important indicator of sexual
well-being [21,22]. Consequently, there is a high
demand for simple instruments assessing PRO,
whereby patients’ own perceptions and ratings of
their health and sexual status are the focus, and
outcomes do not need to be subjectively inter-
preted by physicians or health-care professionals.
Today, one of the most widely used and exten-
sively validated self-report questionnaires in PE
clinical and research practice is the Premature
Ejaculation Diagnostic Tool (PEDT) [23]. The
PEDT was developed on the basis of the DSM-
IV-TR criteria for the diagnosis of PE [24]. Given
that evidence points toward a cultural component
in the perception of PE, availability of translated
versions of the PEDT that can be applied to other
communities and ethnicities may help foster our
understanding of PE and patients’ perception of
PE [25,26]. To date, however, no Persian version
of the PEDT for the assessment of PE in Iranian
populations exists. Therefore, the aim of the
present study was to translate and culturally vali-
date the PEDT in a sample of Iranian men with
and without a clinical diagnosis of PE.
Methods
Data collection took place fromMarch 2012 to July
2012. Two independent samples were included in
this study.Using a convenience sampling approach,
patients with a DSM-IV-TR diagnosis of PE were
consecutively selected from 10 urology clinics
acrossTehran, Iran, and included in the ﬁrst sample
(i.e., the case sample) [27]. Inclusion criteria were as
follows: being older than 18 years; being in a stable
sexual relationship with a female partner for at least
6 months; a clinical diagnosis of PE; consenting to
participate in the study. Individuals suffering from
ED as assessed by the International Index of Erec-
tile Function (IIEF-15) [28,29], takingmedications
for the treatment of sexual problems (such as
phosphodiesterase inhibitors), and suffering from
depression (as assessed by the Depression Anxiety
Stress Scale, DASS) or from cardiovascular dis-
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eases, hypertension, and/or diabetes were excluded
from the study [30]. Patients were further asked to
complete the DASS and the IIEF for the screening
of depression andED. In the end, a total of 269men
were eligible to participate and be included in the
“case” sample.
Individuals for the control samplewere recruited
across three randomly selected health centers
across Tehran. These health centers were afﬁliated
with either Shahid Beheshti University of Medical
Sciences or TehranUniversity ofMedical Sciences.
A multistage cluster random-sampling method was
used to recruit healthy men. All individuals visiting
these health centers have health records with
detailed information regarding their health status.
From these health centers, 150 ﬁles were randomly
selected, andmen older than 18 years who had been
in a stable sexual relationship with a female partner
for at least 6 months were invited to participate in
the study.The same inclusion and exclusion criteria
as in the case sample applied, except for the clinical
PE diagnosis. All individuals eligible to be included
in the control sample were further examined by a
urologist to ensure that they were not suffering
from PE and/or ED. In the end, a total of 303 men
were included in the control sample. Written
consent was obtained from every individual before
enrollment in this study. The project was approved
by the Ethics Committee of Qazvin University of
Medical Sciences.
Measures
A self-constructed questionnaire was used to
collect information on demographic characteris-
tics of the participants, such as age, marriage/
relationship duration, weight, height, educational
status, family income, and current smoking status.
PEDT
For the assessment of PE status, the PEDT was
used. This ﬁve-item questionnaire was developed
according to the DSM-IV-TR criteria used to
diagnose PE [31]. The questionnaire covers the
following ﬁve domains: ejaculation control, fre-
quency of PE, ejaculation with minimal sexual
stimulation, distress, and interpersonal difﬁculty.
Response options for all items are on a ﬁve-point
Likert-type scale ranging from 0 to 4, with higher
scores indicating more sexual impairment. The
total score is computed by summing up all item
scores. The following, previously suggested classi-
ﬁcation was applied: “no PE” (scores ≤ 8), “prob-
able PE” (scores 9–10), and “PE” (scores ≥ 11)
[31,32]. The PEDT can be used in clinical practice
as a standardized short scale to screen people for
PE based on different aspects relevant to the
condition, such as frequency of PE events, per-
ceived control, and personal distress associated
with ejaculation, along with interpersonal difﬁcul-
ties and ejaculation with minimal sexual stimula-
tion [26,31]. The scale may further be used for
research purposes to differentiate between patients
and healthy controls or to monitor treatment out-
comes in clinical trials [32]. The psychometric
properties of the PEDT were conﬁrmed in the
original validation study conducted by Symonds
et al. [31]. Furthermore, a number of validation
studies conducted in the United States and across
Europe have provided consistent support for the
validity and reliability of the measure [26,31,32].
IELT
To objectively complement the subjective assess-
ment of PE, participantswere asked to record IELT
by using a stopwatch to measure the time between
vaginal intromission and start of ejaculation [23].
DASS-21
The 21-item DASS-21 was used to screen patients
for symptoms of depression, stress, and anxiety
[33]. Each of the three dimensions consists of seven
items, rated on a Likert-type scale ranging from 0
to 3. Higher scores indicate more symptoms of
depression, anxiety, or stress. Scores greater than 4,
3, and 7, respectively, indicate pathological levels of
depression, anxiety, and stress. The DASS-21 has
been widely used and extensively validated [33].
Procedure
All individuals consenting to participate in this
study and meeting the inclusion criteria (n = 269
cases, n = 289 controls) were provided with
detailed information on the study procedure and
aims by a nurse and were given the PEDT on site
for baseline assessment. Next, the participants’
wives were trained by the nurses in how to use the
stopwatch and were asked to record IELT for each
sexual intercourse during a period of 4 weeks.
After the 4 weeks, male participants were asked to
complete the PEDT for the second time for the
follow-up assessment.
Translation Procedure
The translation procedure (English to Persian)
was performed according to the widely accepted
recommendations of Brislin et al. [34–37]. First,
the original English version of the PEDT was
independently translated into Persian by two
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bilingual translators whose native language was
English. Second, the two translators and the
project manager compared the translations and
reconciled any discrepancies to produce a uniﬁed
Persian version. Next, a panel of experts assessed
the interim version of the PEDT in terms of face
validity and content validity. This preliminary
Persian version of the PEDT was then back-
translated into English by two different native
English-speaking bilingual translators. Then, the
resulting questionnaire was again compared with
the original English PEDT version. In a ﬁnal step,
the preliminary Persian version of the PEDT was
piloted in 28 Iranian patients with PE to ensure
the comprehensiveness of the introduction and
questionnaire items.
Statistical Analysis
Internal consistency and test–retest reliability
were used to examine the reliability of the PEDT.
Cronbach’s alpha coefﬁcient (α) was computed to
assess the internal consistency of the translated
questionnaire. Values ≥ 0.70 were considered
acceptable [38]. The reproducibility of the PEDT
was examined using a test–retest method based on
two different measurement points (i.e., baseline
and four weeks later). Intraclass correlation coef-
ﬁcients (ICCs) ≥ 0.70 were considered satisfactory
[38]. The ICCs were computed using a one-way
analysis of variance with patients as the random
factor [39].
Convergent validity was examined using one-
trait scaling analysis. In this procedure, the corre-
lations between each questionnaire item and the
total questionnaire score are generated. Spearman
correlation coefﬁcients were computed to assess
convergent validity. Convergent validity was
assumed if all of the questionnaire items showed
correlation at r > 0.40 with the total score for their
own scale [40]. Additionally, Spearman correlation
coefﬁcients between the PEDT and IELT out-
comes were computed to further support the con-
vergent validity of the PEDT scale.
The discriminant validity of the PEDT was
assessed by known-groups validation. In this pro-
cedure, differences between item scores were
examined in terms of the presence or absence of
PE among cases and healthy controls. We hypoth-
esized that men with PE would report higher
scores (i.e., more impairment) across the PEDT
items in comparison with the controls [24]. A
nonparametric Mann–Whitney U-test was used to
compare the mean PEDT ranked-response item
scores between the case and the control group. All
P values were adjusted for multiple comparison
using the Benjamini–Hochberg procedure [41].
The sensitivity and speciﬁcity of the PEDT
scores were examined using receiver operating
characteristics (ROC). The area under the curve
(AUC) was used to assess the ability of the PEDT
to differentiate between healthy individuals and
individuals with PE. According to Greiner et al.,
AUC values < 0.5, 0.5–0.7, 0.9–0.99, and 1 are
nonpredictive, less predictive, moderately predic-
tive, highly predictive, and perfectly predictive,
respectively [42].
The factor structure of the PEDT was assessed
using exploratory factor analysis (EFA) and con-
ﬁrmatory factor analysis (CFA). Because of the
ordinal nature of the data (i.e., Likert-type
ratings), both EFA and CFA were performed in an
ordinal manner. In the case sample, ordinal EFA
was performed using LISREL 8.80 [43]. A Kaiser–
Meyer–Olkin (KMO) value > 0.70, a signiﬁcant
Bartlett’s test of sphericity, and eigenvalues > 1
were considered to indicate the best ﬁt for the
questionnaire items included in the factor analysis.
Furthermore, varimax rotation was used to rotate
the axes such that the eigenvectors remained
orthogonal and that the different factors remained
uncorrelated while being rotated.
CFA using the weighted least-squares method
was conducted to compare the hypothesized factor
structure with the observed data. In addition, an
asymptomatic covariance matrix was computed
[44]. Various well-established model ﬁt indices
were considered to assess themodel ﬁt: χ2-test, root
mean square error of approximation (RMSEA),
goodness-of-ﬁt index (GFI), adjusted GFI (AGFI),
comparative ﬁt index (CFI), normed ﬁt index
(NFI), standardized root mean square residual
(SRMR), and χ2/df ratio. An RMSEA < 0.080
indicates an acceptable ﬁt. GFI, AGFI, and
CFI values > 0.90 were considered acceptable. A
SRMR < 0.08 indicates an adequate ﬁt [44]. A χ2/df
ratio < 5 was regarded a reasonably good ﬁt.
To assess factorial invariance among men with
and without PE, a multigroup CFA was per-
formed. Horn and McArdle introduced two hier-
archical levels of factorial invariance [45]. The ﬁrst
level deals with conﬁgural invariance and assumes
that the factor structure and model speciﬁcations
are equal across groups. It is used to ensure that
individuals in each group use the same conceptual
framework to answer the questions. The main
assumption of conﬁgural invariance is that the
number of factors and the pattern of salient factor
loadings are constrained to be equal while the
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magnitudes of these loadings are not [45]. In the
second level, the equality of factor loadings across
groups is tested (i.e., metric invariance). The
χ2-test and changes in CFI were used to assess the
relative ﬁt of the nested measurement equivalence
models. It has to be noted that the χ2-test is rela-
tively sensitive to sample size; therefore, Cheung
and Rensvold recommended also using the differ-
ence in CFI values (ΔCFI) for nested models [46].
CFI value differences ≤ 0.01 between the nested
models were considered to be acceptable and indi-
cated model invariance [46].
Results
Sample characteristics are listed in Table 1.
Approximately 5% (n = 14) of healthy men did not
participate in the study due to unwillingness. The
mean ages of men with and without PE were 35.3
years and 34.9 years, respectively. In terms of
family income, the majority of participants
reported a monthly income between US$200 and
US$1,000. Most of the subjects were nonsmokers
(70%). No statistically signiﬁcant differences in
sociodemographic characteristics between men
with and without a clinical diagnosis of PE could
be detected.
Scale Reliability
Cronbach’s alpha coefﬁcient for the PEDT was
0.89. Test–retest reliability was good, with all
single items and the total score being consistent
between the two measurement points and being
signiﬁcantly correlated (P < 0.05). The test–retest
correlation coefﬁcients of each item for both
patient and control groups were higher than 0.81,
and the correlation coefﬁcients for the total score
were 0.92 and 0.94 for the patient and control
groups, respectively.
Results from the one-trait scaling analysis
carried out to examine the convergent validity of
the PEDT are shown in Table 2. All ﬁve question-
naire items correlated at r = 0.40 or greater with
the total score. All correlations were based on the
corrected item-to-total correlations.
Convergent validity of the PEDT was good,
with a high negative linear correlation (r = −0.82,
P < 0.001) between the questionnaire and the
IELT (Figure 1). In other words, with increasing
PEDT total score, the geometric mean IELT
declined. Results of the discriminant analysis are
summarized in Table 3. As expected, subjects with
PE reported higher PEDT scores compared with
subjects without PE.
The ROC curve showed a large and statistic-
ally signiﬁcant AUC of 0.89 (95% CI 0.87–0.90)
for discrimination between cases and controls.
A score of 9.1 was considered the best cutoff to
discriminate between healthy men and men with
PE as deﬁned by the DSM-IV-TR, resulting in
a sensitivity of 92% and a speciﬁcity of 83%
(Figure 2). The positive predictive value of the test
was 0.83.
Findings from the EFA indicated that a single-
factor structure provided the best ﬁt to the data,
with eigenvalues of >1.0 (KMO = 0.70) and a sig-
niﬁcant Bartlett’s test of sphericity (χ2 = 57.72(10),
P < 0.001). All items showed considerable factor
loadings, ranging from 0.70 to 0.83. According to
the CFA goodness-of-ﬁt measures, the unidimen-
sional PEDT was acceptable, with χ2 = 12.86
(df = 5, P = 0.02), GFI = 0.99, AGFI = 0.97, CFI =
0.98, NFI = 0.97, SRMR = 0.028, and RMSEA =
0.053. The standardized regression coefﬁcients
ranged from 0.16 to 0.70.
Table 1 Sample characteristics for men with and without
PE
Characteristic
Healthy control
(n = 289)
Men with PE
(n = 269)
Age, mean (SD) 34.99 (7.45) 35.36 (7.55)
Duration of marriage (yrs),
mean (SD)
8.30 (7.67) 7.02 (7.59)
Height, mean (SD) 167.95 (8.18) 178.51 (10.08)
Weight, mean (SD) 73.83 (9.85) 79.4 (11.12)
Education, n (%)
Unlettered 8 (2.8) 13 (4.8)
Primary school 63 (21.8) 55 (20.4)
Secondary school 123 (42.6) 119 (44.2)
College or higher 95 (32.9) 82 (30.5)
Family income (US$), n (%)
<200 88 (30.4) 79 (29.4)
200–1,000 179 (61.9) 157 (58.4)
>1,000 22 (7.6) 33 (12.3)
Current smoker, n (%)
Yes 80 (27.7) 86 (32.0)
No 209 (72.3) 183 (68.0)
Table 2 Correlations among PEDT items for healthy
men and men with PE
Item 1 2 3 4 5
Total score
PEDT
1 — 0.44 0.33 0.36 0.42 0.62
2 0.48 — 0.36 0.48 0.51 0.64
3 0.47 0.52 — 0.55 0.42 0.63
4 0.62 0.47 0.59 — 0.46 0.65
5 0.73 0.52 0.49 0.50 — 0.74
Total score 0.55 0.68 0.75 0.62 0.73 —
P < 0.01 for all values.
Correlations for men with PE are presented above the diagonal; correlations
for healthy men are presented below the diagonal.
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CFA results for conﬁgural invariance of the
PEDT were as follows: χ2 = 55.79 (df = 19,
P = 0.02), GFI = 0.88, CFI = 0.93, NFI = 0.92,
SRMR = 0.048, RMSEA = 0.066. The ﬁt indices
assessing metric invariance further supported the
ﬁt of the model to the data: χ2 = 41.34 (df = 15,
P = 0.02), GFI = 0.91, CFI = 0.94, NFI = 0.92,
SRMR = 0.032, RMSEA = 0.074, ΔCFI < 0.01. In
summary, these results indicate that the PEDT
items were understood and interpreted similarly in
both cases and controls (Figure 3).
Discussion
Developed by Symonds et al. based on the DSM-
IV-TR deﬁned criteria for the assessment of PE,
the PEDT represents a quantitative measure for
the assessment of PE that overcomes traditional
limitations of previous measures [31]. Previous
studies have repeatedly shown that each PE
dimension is substantially inﬂuenced by cultural
factors and that men’s perceptions of PE differ
signiﬁcantly across different cultures. Therefore,
cultural adaption of the measure and evaluation
of cross-cultural applicability of the measure is
crucial. The aim of the current study was to
Figure 1 Scatter plot of total PEDT
scores vs. geometric mean IELT.
r = −0.82, P < 0.001.
Table 3 Comparison of the PEDT item and total scores
for men with and without PE
Item
Healthy men
(n = 289)
Men with PE
(n = 269)
1 1.13 3.18
2 1.46 3.14
3 1.03 3.00
4 1.15 3.05
5 1.12 3.30
Total score 6.67 16.73
All item scores and total score showed statistically significant differences
according to male sexual health status (i.e., between men with and without
PE), as determined using the Benjamini–Hochberg procedure.
Figure 2 Receiver operator characteristic curves for the
PEDT (blue line) and the DSM-IV-TR definition of PE (green
line). Diagonal segments are produced by ties.
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demonstrate the consistency and preservation of
the psychometric properties of the translated and
culturally adapted version of the PEDT for use in
the Iranian male population.
Different diagnostic methods for the identiﬁca-
tion of PE exist, including objective outcome
measures such as IELT [25] and self-report ques-
tionnaires such as the Premature Ejaculation
Proﬁle (PEP) [47], the Chinese Index of Prema-
ture Ejaculation (CIPE), the Index of Premature
Ejaculation (IPE) [48], and the Clinical Global
Impression of Change (CGIC) [49]. Among these
assessment instruments, only the IELT and the
CIPE have been proven to have good sensitivity
and speciﬁcity proﬁles and are therefore able to
differentiate between men with and without PE.
There are, however, several limitations to these
instruments. The CIPE, for example, is a measure
primarily applied to monitor and assess the out-
comes of pharmacological interventions and was
not developed based on the DSM-IV-TR diagnos-
tic criteria. Similarly, there are several shortcom-
ings to IELT. First, a number of studies have
indicated that the distribution of IELT data can
potentially be skewed. Second, using a stopwatch
during sexual intercourse interrupts the natural
course of intimate activities and might cause
annoyance and stress, thus aggravating any poten-
tially existent PE and reducing sexual quality [50].
In addition to these limitations, the lack of con-
sensus regarding the deﬁnition of PE is problem-
atic for the use of both objective and subjective
assessment methods [51]. Previous evidence has
demonstrated that urologists’ DSM-IV-TR-based
diagnosis can be subject to diagnostic errors, with
reported risks of false negatives of up to 48%. This
is most likely due to the subjective criteria (e.g.,
ejaculation before or shortly after vaginal penetra-
tion) included in the DSM-IV-TR diagnosis,
which make accurate and uniform interpretation
difﬁcult [52]. Needless to say, there is a vital need
to limit these diagnostic errors. Furthermore, to
enhance successful epidemiologic research on PE,
instruments developed on a sound scientiﬁc basis
allowing accurate classiﬁcation and uniform appli-
cation of PE deﬁnitions, as well as consistent study
designs providing meaningful end points and valid
outcomes, are necessary and should be considered
in all future research.
The internal consistencies for the current
sample were very high, with α > 0.70 (0.89), indi-
cating excellent internal consistency. This is
higher than the internal consistencies reported
by the original validation study of the PEDT on
309 men with PE, where the authors found a mar-
ginal threshold value of 0.71 for the ﬁve-item
PEDT, while the overall Cronbach’s alpha for the
nine-item version was 0.86 [31]. Similarly,
researchers validating the Turkish version of the
PEDT (n = 94 men with PE) reported consider-
ably lower internal consistencies (r = 0.77) com-
pared with our study [26]. A potential explanation
for these disparities may be that the estimation of
Cronbach’s alpha is affected by the sample size and
number of items included in the scale (i.e., a nine-
item PEDT version exists and has been used in
some of these studies). We further report a highly
signiﬁcant test–retest reproducibility (r > 0.70 for
all ICCs), indicating excellent stability of the
instrument. Again, this was considerably higher
compared with the ﬁndings from the original
validation study of the English version of the
questionnaire (0.73), as well as the Korean (0.88)
and Turkish (0.90) versions [24,26,31]. A potential
explanation for these disparities may be the rela-
tively young mean age of our sample compared
with previous studies. Research has repeatedly
shown that the prevalence of PE seems to be
higher among older men compared with younger
ones [53]. Therefore, younger men might be more
stable in terms of their ejaculatory function and
control compared to older men. This is somewhat
supported by a study where test–retest reliability
of the PEDT (ICC = 0.88) was higher in younger
patients compared with older patients [32].
One-trait scaling analysis revealed high corre-
lations of the PEDT items with total score on their
own scale (all r > 0.60). Furthermore, interitem
Figure 3 One-factor structure of the PEDT. χ2 = 12.86
(df = 5, P = 0.02475), RMSEA = 0.053.
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correlations indicated that all items were signiﬁ-
cantly correlated with each other. These ﬁndings
conﬁrm the convergent validity of the scale and
suggest that all PEDT items are linearly correlated
with the concept being measured (i.e., premature
ejaculation). It should be noted, however, that the
PEDT has only one scale, which renders compari-
son of the correlations between items and with
other scales impossible. Because of this, we used
known-group analyses to assess the discriminant
validity of the scale (i.e., healthy men vs. men with
PE). Men with PE scored lower compared with
healthy men on all PEDT items, as well as on the
total score. This trend remained signiﬁcant even
when P values were adjusted for multiple compari-
sons, therefore supporting the hypothesis that the
PEDT is able to discriminate between men with
and without PE. Overall, our ﬁndings were similar
to the ﬁndings from validation studies conducted
in the United States and Korea [24,31].
Symonds et al. demonstrated that a score ≥ 9
for the PEDT [31] was the best differentiation
cutoff between men with and without PE. In the
present study, the optimal cutoff value of PEDT
for a PE diagnosis was 9.1, with a sensitivity of
92% and a speciﬁcity of 83%. Therefore, the
results of the study support a similar scoring
system for the Persian version. Furthermore, these
results indicate that the PEDT has a diagnostic
accuracy that is comparable with that of IELT for
screening men with unknown sexual health status
in clinics and other medical settings.
Convergent validity of the PEDTwas examined
by exploring the correlations between IELT and
PEDT outcomes. The results revealed that the
PEDT total score correlated negatively with mean
IELT. Again, our ﬁndings were in line with the
results from previous studies [24,26].
The EFA revealed a unidimensional factor
structure for the Iranian version of the PEDT.
With regard to construct validity, we were success-
ful in replicating the single-factor structure of the
original English PEDT with moderate to high
standardized factor loadings (P < 0.05) for all items
except item 5, thus supporting the factorial validity
of the instrument in our Iranian sample [24,31].
In the present study, the measurement
invariance of the ﬁve items of the PEDT was
evaluated to ensure that the tool yielded the same
underlying construct across men with different
sexual health statuses (i.e., with and without PE).
Our results revealed that there were no signiﬁcant
differences in item location between men with and
without PE, suggesting stability of the item loca-
tions when the instrument is used for screening
purposes (i.e., in the general population). In other
words, both men with PE and those without PE
perceived the PEDT items similarly.
As in all studies, there were several potential
limitations to the research design. First, the
sample size was relatively small, thus limiting the
generalizability of the results. Second, the partici-
pants included in this study were relatively young
(mean ages of 35.3 years in the case group and 34.9
years in the control group), and therefore extrapo-
lation of the ﬁndings to other age groups or popu-
lations can only be limited. Future studies should
investigate the invariance of the PEDT in men
across different age clusters, different ethnicities,
and different stages of PE using longitudinal
approaches and larger samples. Finally, the strong
correlation between IELT and the PEDT demon-
strates that these two tools may measure the same
thing. Thus, there is a lack of evidence for the
divergent validity of the PEDT in this speciﬁc
population. Therefore, further research is needed
to explore the correlation between the PEDT and
self-reported IELT.
Conclusion
In conclusion, the translated and culturally
adapted Iranian version of the PEDT demon-
strates high internal reliability and good construct
validity and can be applied as an assessment tool
for erectile function across Iranian men with and
without PE. The PEDT will be especially useful
where cultural barriers may hinder the use of other
assessment instruments, such as IELT.
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